Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-22 19:43 | 2025-12-18 | KYTX | Kyverna Therapeutics, Inc. | SEIDENBERG BETH C | Director | Biological Products, (No Diagnostic Substances) | BUY | $7.50 | 133,333 | $999,998 | 869,317 | +18.1% |
| 2024-10-30 23:06 | 2024-10-28 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | SALE | $48.03 | 15,000 | $720,494 | 131,553 | -10.2% |
| 2024-09-20 23:45 | 2024-09-18 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | SALE | $42.26 | 16,476 | $696,233 | 146,553 | -10.1% |
| 2023-07-20 23:20 | 2023-07-18 | SGMT | Sagimet Biosciences Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $16.00 | 46,875 | $750,000 | 46,875 | +100.0% |
| 2023-05-12 04:13 | 2023-05-09 | SLRN | N/A | SEIDENBERG BETH C | Director, 10% owner | Other | BUY | $18.00 | 1,310,000 | $23,580,000 | 60,000 | +100.0% |
| 2023-04-03 23:05 | 2023-03-30 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 2,300 | $16,651 | 1,949,295 | +0.1% |
| 2023-03-30 23:07 | 2023-03-28 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 23,908 | $173,192 | 1,946,995 | +1.2% |
| 2023-03-28 23:05 | 2023-03-24 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 3,466 | $25,102 | 1,923,087 | +0.2% |
| 2023-03-21 23:40 | 2023-03-17 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.13 | 89,297 | $636,911 | 1,919,621 | +4.9% |
| 2023-03-17 23:10 | 2023-03-15 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.10 | 92,941 | $660,281 | 1,830,324 | +5.3% |
| 2023-03-14 23:05 | 2023-03-10 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.16 | 48,003 | $343,485 | 1,737,383 | +2.8% |
| 2023-03-08 00:07 | 2023-03-03 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.25 | 1,000 | $7,245 | 1,689,380 | +0.1% |
| 2023-03-04 00:07 | 2023-03-01 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 23,478 | $170,046 | 1,688,380 | +1.4% |
| 2023-02-28 00:07 | 2023-02-23 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 200 | $1,447 | 1,664,902 | +0.0% |
| 2023-02-16 02:32 | 2023-02-13 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.20 | 10,072 | $72,490 | 1,664,702 | +0.6% |
| 2023-02-14 00:04 | 2023-02-09 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.25 | 400 | $2,900 | 1,654,630 | +0.0% |
| 2023-02-10 00:36 | 2023-02-03 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.10 | 311,078 | $2,209,587 | 1,654,230 | +23.2% |
| 2021-04-20 04:45 | 2021-04-15 | PGNY | Progyny, Inc. | SEIDENBERG BETH C | Director | Services-Misc Health & Allied Services, NEC | SALE | $50.32 | 18,127 | $912,151 | 8,805,015 | -0.2% |
| 2020-12-16 05:47 | 2020-12-14 | PGNY | Progyny, Inc. | SEIDENBERG BETH C | Director | Services-Misc Health & Allied Services, NEC | SALE | $42.00 | 38,461 | $1,615,362 | 0 | -100.0% |
| 2020-12-02 01:14 | 2020-11-27 | PGNY | Progyny, Inc. | SEIDENBERG BETH C | Director | Services-Misc Health & Allied Services, NEC | SALE | $36.00 | 19,231 | $692,316 | 38,461 | -33.3% |
| 2020-08-14 01:59 | 2020-08-11 | PGNY | Progyny, Inc. | SEIDENBERG BETH C | Director | Services-Misc Health & Allied Services, NEC | SALE | $30.00 | 19,231 | $576,930 | 57,692 | -25.0% |
| 2019-10-31 04:11 | 2019-10-29 | PGNY | Progyny, Inc. | SEIDENBERG BETH C | Director | Services-Misc Health & Allied Services, NEC | BUY | $13.00 | 76,923 | $999,999 | 76,923 | +100.0% |
| 2016-03-18 23:30 | 2016-03-18 | TSRO | N/A | SEIDENBERG BETH C | Director | Other | BUY | $35.19 | 1,420,858 | $49,999,993 | 227,255 | +100.0% |
| 2014-02-13 04:05 | 2014-02-10 | EPZM | N/A | SEIDENBERG BETH C | Director, 10% owner | Other | SALE | $27.64 | 388,584 | $10,740,967 | 3,838,167 | -9.2% |
| 2012-07-07 00:29 | 2012-07-03 | TSRO | N/A | SEIDENBERG BETH C | Director | Other | BUY | $13.50 | 222,222 | $2,999,997 | 171,028 | +100.0% |
| 2006-05-05 23:18 | 2006-05-03 | BCRX | BIOCRYST PHARMACEUTICALS INC | SEIDENBERG BETH C | Director | Biological Products, (No Diagnostic Substances) | BUY | $15.34 | 3,000 | $46,030 | 3,000 | +100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.